array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "ROCHE DIAGNOSTICS LIMITED"
["slug"]=>
string(34) "ef866-gb-roche-diagnostics-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/5ce04174-8fff-4069-9bd1-2ef80ada854c"
["description"]=>
string(1583) "Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation"
["address_street"]=>
string(14) "Charles Avenue"
["address_place"]=>
string(12) "BURGESS HILL"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1956-09-14"
["website_domain"]=>
string(9) "roche.com"
["website_url"]=>
string(29) "https://diagnostics.roche.com"
["industry_codes"]=>
array(1) {
[0]=>
string(43) "Business Services, Not Elsewhere Classified"
}
["employee_count"]=>
int(658)
["article_count"]=>
int(3435)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(79) "The 30 winners of the tenders awarded, 940 thousand euros in research - Vita.it"
["snippet_en"]=>
string(132) "The winning projects of the calls for independent research, clinical research and services for multiple sclerosis were awarded today"
["url"]=>
string(79) "https://www.vita.it/premiati-i-30-vincitori-dei-bandi-940-mila-euro-in-ricerca/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/9a7b5ea0-f7a9-46c0-a517-f90958879540"
["source"]=>
string(7) "vita.it"
["publication_date"]=>
string(10) "2024-04-03"
["categories"]=>
array(2) {
[0]=>
string(15) "Deals & Tenders"
[1]=>
string(17) "Academic Research"
}
}
[1]=>
array(7) {
["title_en"]=>
string(109) "The ASL Cn2 Alba-Bra wins the Roche tender for clinical research to support data managers and research nurses"
["snippet_en"]=>
string(131) "Scholarship for a project selected and evaluated by the Gimbe Foundation on radiotherapy in patients suffering from prostate cancer"
["url"]=>
string(137) "https://www.targatocn.it/2024/04/26/leggi-notizia/argomenti/salute-e-benessere/articolo/asl-cn2-alba-bra-bando-roche-ricerca-clinica.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/5d4ed448-b0bb-4693-8a88-f405966e57a9"
["source"]=>
string(12) "targatocn.it"
["publication_date"]=>
string(10) "2024-04-02"
["categories"]=>
array(3) {
[0]=>
string(15) "Deals & Tenders"
[1]=>
string(17) "Academic Research"
[2]=>
string(5) "R & D"
}
}
[2]=>
array(7) {
["title_en"]=>
string(92) "Lonza acquires biologics manufacturing plant in California from Roche - Chemical Engineering"
["snippet_en"]=>
string(153) "Lonza AG (Basel, Switzerland) announced it has signed an agreement to acquire the Genentech large-scale biologics manufacturing site in Vacaville, Calif."
["url"]=>
string(100) "https://www.chemengonline.com/lonza-acquires-biologics-manufacturing-plant-in-california-from-roche/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/0a0177f6-d1f2-4e79-ba96-d58e0c753016"
["source"]=>
string(17) "chemengonline.com"
["publication_date"]=>
string(10) "2024-03-20"
["categories"]=>
array(3) {
[0]=>
string(15) "Deals & Tenders"
[1]=>
string(11) "Acquisition"
[2]=>
string(13) "Collaboration"
}
}
[3]=>
array(7) {
["title_en"]=>
string(54) "Swiss Firm Lonza Snaps Up Roche Site In US For $1.2 Bn"
["snippet_en"]=>
string(180) "Swiss healthcare manufacturing group Lonza announced Wednesday that it had reached an agreement to buy a US biologics site from pharmaceutical giant Roche for $1.2 billion in cash."
["url"]=>
string(91) "https://www.barrons.com/news/swiss-firm-lonza-snaps-up-roche-site-in-us-for-1-2-bn-4fae6129"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c49569cf-fe03-433a-865a-8a14811e9517"
["source"]=>
string(11) "barrons.com"
["publication_date"]=>
string(10) "2024-03-20"
["categories"]=>
array(2) {
[0]=>
string(15) "Deals & Tenders"
[1]=>
string(11) "Acquisition"
}
}
[4]=>
array(7) {
["title_en"]=>
string(57) "Roche snaps up ex-US rights to Sarepta's DMD gene therapy"
["snippet_en"]=>
string(301) "Roche has bought ex-US rights to Sarepta’ s Duchenne muscular dystrophy( DMD) gene therapy in a potential multi-billion dollar deal.The big Swiss pharma will pay$ 750 million cash up front and$ 400 in equity under the deal, and will pay Sarepta up to$ 1.7 billion in regulatory and sales milestones,"
["url"]=>
string(86) "https://pharmaphorum.com/news/roche-snaps-up-ex-us-rights-to-sareptas-dmd-gene-therapy"
["image_url"]=>
NULL
["source"]=>
string(16) "pharmaphorum.com"
["publication_date"]=>
string(10) "2024-02-05"
["categories"]=>
array(4) {
[0]=>
string(15) "Deals & Tenders"
[1]=>
string(11) "Geopolitics"
[2]=>
string(46) "Management of Legal and Regulatory Environment"
[3]=>
string(36) "Human Rights and Community Relations"
}
}
[5]=>
array(7) {
["title_en"]=>
string(57) "Hookipa Pharma provides update as Roche pulls out of deal"
["snippet_en"]=>
string(57) "Hookipa Pharma provides update as Roche pulls out of deal"
["url"]=>
string(97) "https://www.thepharmaletter.com/article/hookipa-pharma-provides-update-as-roche-pulls-out-of-deal"
["image_url"]=>
NULL
["source"]=>
string(19) "thepharmaletter.com"
["publication_date"]=>
string(10) "2024-01-30"
["categories"]=>
array(1) {
[0]=>
string(15) "Deals & Tenders"
}
}
[6]=>
array(7) {
["title_en"]=>
string(57) "Sarawak hospital chosen for first-in-human clinical trial"
["snippet_en"]=>
string(137) "HOSPITAL Umum Sarawak (SGH) in Kuching has been selected by Roche Pharma-ceuticals as its site for a first-in-human (FIH) clinical trial."
["url"]=>
string(112) "https://www.thestar.com.my/metro/metro-news/2024/01/11/sarawak-hospital-chosen-for-first-in-human-clinical-trial"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/840bd9f8-4c43-4c7c-ab42-ff192ff2d44a"
["source"]=>
string(14) "thestar.com.my"
["publication_date"]=>
string(10) "2024-01-10"
["categories"]=>
array(2) {
[0]=>
string(15) "Deals & Tenders"
[1]=>
string(17) "Academic Research"
}
}
[7]=>
array(7) {
["title_en"]=>
string(116) "J&J acquisition of Ambrx bolsters cancer ADC portfolio amidst big pharma’s growing investment trend - BioVoiceNews"
["snippet_en"]=>
string(112) "Prior to the announced J&J deal, last year alone saw 155 deals struck for the modality, 14 of which were in M&A."
["url"]=>
string(123) "https://biovoicenews.com/jj-acquisition-of-ambrx-bolsters-cancer-adc-portfolio-amidst-big-pharmas-growing-investment-trend/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/421affd8-3bb8-4c72-8f84-1a720fdba0bc"
["source"]=>
string(16) "biovoicenews.com"
["publication_date"]=>
string(10) "2024-01-10"
["categories"]=>
array(5) {
[0]=>
string(15) "Deals & Tenders"
[1]=>
string(6) "Merger"
[2]=>
string(15) "Market Movement"
[3]=>
string(11) "Acquisition"
[4]=>
string(25) "Business Model Resilience"
}
}
[8]=>
array(7) {
["title_en"]=>
string(60) "Roche is still hungry for agreements in the field of obesity"
["snippet_en"]=>
string(112) "In December, Roche took over Carmot Therapeutics in a deal that could potentially amount to 3.1 billion. dollar."
["url"]=>
string(39) "https://medwatch.dk/article16745135.ece"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6a40ccd7-4370-4b5d-bdb5-b14e3d8747a1"
["source"]=>
string(11) "medwatch.dk"
["publication_date"]=>
string(10) "2024-01-10"
["categories"]=>
array(2) {
[0]=>
string(15) "Deals & Tenders"
[1]=>
string(21) "Competitive Behaviour"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(217)
}
[1]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(204)
}
[2]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(192)
}
[3]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(156)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(153)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(148)
}
[6]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(137)
}
[7]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(136)
}
[8]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(111)
}
[9]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(105)
}
[10]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(102)
}
[11]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(97)
}
[12]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(92)
}
[13]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(89)
}
[14]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(86)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(69)
}
[16]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(65)
}
[17]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(64)
}
[18]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(62)
}
[19]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(49)
}
[20]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(42)
}
[21]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(40)
}
[22]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(39)
}
[23]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(38)
}
[24]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(33)
}
[25]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(33)
}
[26]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(32)
}
[27]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(32)
}
[28]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(32)
}
[29]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(32)
}
}
}
ef866-gb-roche-diagnostics-limited
ROCHE DIAGNOSTICS LIMITED
Location
Founded
1956-09-14
Website
https://diagnostics.roche.com
Articles
3435 Articles
Category
Business Services, Not Elsewhere Classified
Description
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
Lonza AG (Basel, Switzerland) announced it has signed an agreement to acquire the Genentech large-scale biologics manufacturing site in Vacaville, Calif.
Swiss healthcare manufacturing group Lonza announced Wednesday that it had reached an agreement to buy a US biologics site from pharmaceutical giant Roche for $1.2 billion in cash.
Roche has bought ex-US rights to Sarepta’ s Duchenne muscular dystrophy( DMD) gene therapy in a potential multi-billion dollar deal.The big Swiss pharma will pay$ 750 million cash up front and$ 400 in equity under the deal, and will pay Sarepta up to$ 1.7 billion in regulatory and sales milestones,
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
